Vanda Pharmaceuticals Inc.
VNDA
Revenue
53.19M
▲5.53M▲11.61%
3 Months ChangeAssets
656.20M
▲11.09M▲1.72%
3 Months ChangeLiabilities
117.66M
▲13.77M▲13.25%
3 Months ChangeFree Cash Flow
7.56M
▼-24.19M▼-76.18%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-15
Form 8-K
ID: 0001193125-24-237220
2024-10-03
Form 8-K
ID: 0001193125-24-232306
2024-09-19
Form 8-K
ID: 0001193125-24-221784
2024-08-08
Form 8-K
ID: 0001193125-24-196481
2024-08-01
Form 10-Q
ID: 0001628280-24-033866
2024-07-31
Form 8-K
ID: 0001628280-24-033743
2024-06-20
Form 8-K
ID: 0001193125-24-164545
2024-06-13
Form 8-K
ID: 0001193125-24-160755
2024-06-06
Form 8-K
ID: 0001193125-24-156117
2024-05-24
Form 8-K
ID: 0001628280-24-025254